Aadi Bioscience, Inc. (AADI)
USD 2.29
(-4.18%)
USD 2.29
(-4.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -59.66 Million | -49.64 Million | -22.42 Million | -12.7 Million | -23.85 Million | -5.8 Million |
| Net Income | -65.76 Million | -60.51 Million | -110.09 Million | -3.47 Million | -23.27 Million | -10.39 Million |
| Depreciation & Amortization | 169 Thousand | 159 Thousand | 105 Thousand | 9000.00 | 76.5 Thousand | 46.68 Thousand |
| Deferred income taxes | 7.02 Million | - | 72.37 Million | 153 Thousand | -2.47 Million | - |
| Stock-based compensation | 11.95 Million | 9.64 Million | 2.1 Million | 139 Thousand | 106.14 Thousand | 3.43 Million |
| Change in working capital | -3.4 Million | -1.82 Million | 12.24 Million | -10.5 Million | -1.89 Million | 1.11 Million |
| Other non-cash items | -9.64 Million | 2.89 Million | 836 Thousand | 982 Thousand | 3.6 Million | 1.66 Million |
| Investing Cash Flow | 83.2 Million | -132.88 Million | 25.15 Million | -19.02 Thousand | -236.95 Thousand | -37.91 Thousand |
| Investments in PPE | -3.97 Million | -444 Thousand | -46 Thousand | - | -236.95 Thousand | -37.91 Thousand |
| Acquisitions | - | 132.44 Million | 25.19 Million | - | - | - |
| Investment purchases | -64.43 Million | -145.19 Million | - | - | - | - |
| Sales/Maturities of investments | 151.61 Million | 12.75 Million | - | - | - | - |
| Other Investing Activities | -1.00 | -132.44 Million | -4.5 Million | -19.02 Thousand | -236.95 Thousand | -37.91 Thousand |
| Financing Cash Flow | 326 Thousand | 72.62 Million | 141.8 Million | 1.19 Million | 8.07 Million | 48.19 Million |
| Debt repayment | - | - | - | -997 Thousand | -8.07 Million | - |
| Dividends payments | - | - | -4.41 Million | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 326 Thousand | 72.5 Million | 155 Million | 9.74 Million | - | 51.69 Million |
| Other Financing Activities | 326 Thousand | 120 Thousand | -8.78 Million | -7.55 Million | 8.07 Million | -3.5 Million |
| Accounts receivables | -3.62 Million | -1.86 Million | 14.14 Million | -13.86 Million | -39.7 Thousand | - |
| Accounts payables | -132 Thousand | 3.22 Million | 8.29 Million | 1.07 Million | -2.21 Million | 1.86 Million |
| Inventory | -3.26 Million | -1.86 Million | - | - | 39.7 Thousand | - |
| Other working capital | 3.61 Million | -1.31 Million | -10.19 Million | 2.27 Million | 325.09 Thousand | -754.71 Thousand |
| Cash at beginning of period | 39.01 Million | 148.98 Million | 4.45 Million | 15.96 Million | 62.61 Million | 20.26 Million |
| Cash at end of period | 62.88 Million | 39.08 Million | 148.98 Million | 4.45 Million | 38.52 Million | 62.61 Million |
| Capital Expenditure | -3.97 Million | -444 Thousand | -46 Thousand | - | -236.95 Thousand | -37.91 Thousand |
| Effect of forex changes on cash | - | - | - | 19.02 Thousand | 31.97 Million | - |
| Net cash flow / Change in cash | 23.86 Million | -109.9 Million | 144.53 Million | -11.5 Million | -24.08 Million | 42.34 Million |
| Free Cash Flow | -63.63 Million | -50.08 Million | -22.46 Million | -12.7 Million | -24.08 Million | -5.84 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -14.58 Million | -18.28 Million | -16.26 Million | -65.76 Million | -16.3 Million | -17.97 Million |
| Depreciation & Amortization | 49 Thousand | 50 Thousand | 44 Thousand | 169 Thousand | 44 Thousand | 43 Thousand |
| Deferred income taxes | - | - | -380 Thousand | 7.02 Million | -588 Thousand | -862 Thousand |
| Stock-based compensation | 2.83 Million | 3.58 Million | 3.11 Million | 11.95 Million | 3.04 Million | 3.05 Million |
| Change in working capital | 2.81 Million | -4.75 Million | 3.84 Million | -3.4 Million | 1.73 Million | -1.13 Million |
| Other non-cash items | 115 Thousand | 9.15 Million | 9000.00 | -9.64 Million | 115 Thousand | 115 Thousand |
| Investing Cash Flow | -3.57 Million | 10.55 Million | 3.64 Million | 83.2 Million | 12.66 Million | 50.56 Million |
| Investments in PPE | -541 Thousand | -739 Thousand | -816 Thousand | -3.97 Million | -1.09 Million | -689 Thousand |
| Acquisitions | - | - | -4.46 Million | - | -13.76 Million | - |
| Investment purchases | -18.9 Million | -7.64 Million | -13.89 Million | -64.43 Million | -27.49 Million | - |
| Sales/Maturities of investments | 15.87 Million | 18.94 Million | 18.36 Million | 151.61 Million | 41.25 Million | 51.25 Million |
| Other Investing Activities | -3.03 Million | 11.29 Million | 4.46 Million | -1.00 | 13.76 Million | 51.25 Million |
| Financing Cash Flow | 87 Thousand | -10 Thousand | 80 Thousand | 326 Thousand | -75 Thousand | 313 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 294 Thousand | - | -46 Thousand | 326 Thousand | 51 Thousand | 313 Thousand |
| Other Financing Activities | -7000.00 | -10 Thousand | 80 Thousand | 326 Thousand | -75 Thousand | 313 Thousand |
| Accounts receivables | -987 Thousand | 555 Thousand | 229 Thousand | -3.62 Million | -2.04 Million | 1.88 Million |
| Accounts payables | 2.49 Million | -6.76 Million | 4.81 Million | -132 Thousand | 1.72 Million | -5.12 Million |
| Inventory | -162 Thousand | 490 Thousand | -2.22 Million | -3.26 Million | 322 Thousand | 580 Thousand |
| Other working capital | 1.46 Million | 965 Thousand | 1.02 Million | 3.61 Million | 1.72 Million | 1.52 Million |
| Cash at beginning of period | 53.84 Million | 62.88 Million | 68.8 Million | 39.01 Million | 68.22 Million | 34.11 Million |
| Cash at end of period | 41.2 Million | 53.78 Million | 62.88 Million | 62.88 Million | 68.86 Million | 68.22 Million |
| Capital Expenditure | -541 Thousand | -739 Thousand | -816 Thousand | -3.97 Million | -1.09 Million | -689 Thousand |
| Effect of forex changes on cash | - | - | 59.13 Million | - | -12.83 Million | -46.3 Million |
| Net cash flow / Change in cash | -12.64 Million | -9.1 Million | -5.91 Million | 23.86 Million | 641 Thousand | 34.11 Million |
| Free Cash Flow | -9.69 Million | -20.39 Million | -10.46 Million | -63.63 Million | -13.04 Million | -17.44 Million |
PKTEF
ATHHF
000089
SAINTGOBAIN
HIPO-WT
UCSO